SenesTech, Inc.

Listed Company

SNESCIK 0001680378NasdaqNon-AcceleratedSmaller ReportingAgricultural ChemicalsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$2.22M

Net Income

$-6.38M

Total Assets

$12.84M

Equity

$9.57M

Shares Out

5.30M

Op. Cash Flow

$-5.75M

SNES$1.44−69.46% · past yearDBEQ Basic

Daily closing prices

Business

SenesTech, Inc. develops and commercializes fertility-control and population-management products for rodent pest control, focusing on rats and mice through non-lethal mechanisms. The company's primary products are Evolve Rat and Evolve Mouse (launched 2024, containing cottonseed oil as active ingredient and exempt from federal EPA registration as minimum-risk pesticides) and ContraPest (EPA-registered liquid bait containing VCD and triptolide, approved for all 50 states). Products are distributed through pest management providers, agribusiness, industrial, retail, and international channels; the company manufactures internally in Arizona and seeks to position fertility control as a standard tool within integrated pest management (IPM) programs.

Summary from 10-K filed 2026-03-13

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenues	2	2	1	1	600,000
Cost of sales	833,000	853,000	654,000	555,000	356,000
Gross profit	1	1	539,000	464,000	244,000
Research and development	2	2	1	2	2
Selling, general and administrative	6	6	7	8	7
Total operating expenses	8	7	8	10	9
Loss from operations	−7	−6	−8	−10	−9
Interest income	144,000	56,000	26,000	7,000	4,000
Interest expense	−22,000	−22,000	−4,000	−2,000	−11,000
Miscellaneous income	0	31,000	0	−26,000	22,000
Other income, net	122,000	65,000	22,000	−21,000	666,000
Net loss	−6	−6	−8	−10	−8
Comprehensive loss	−6	−6	−8	−10	−8
Weighted average shares outstanding - basic (in shares)	3	697,974	66,986	65,473	559,591
Weighted average shares outstanding - diluted (in shares)	3	697,974	66,986	65,473	559,591
Loss per share - basic (in dollars per share)	−1.95	−8.86	−115.1	−148.08	−14.77
Loss per share - diluted (in dollars per share)	−1.95	−8.86	−115.1	−148.08	−14.77

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	8	1	5	5	9
Short-Term Investments	994,000	0	—	—	—
Accounts receivable, net	201,000	335,000	95,000	113,000	77,000
Inventory	994,000	794,000	795,000	853,000	1
Prepaid expenses and other current assets	297,000	377,000	388,000	378,000	230,000
Total current assets	10	3	7	6	11
Right to use assets, operating leases	2	0	210,000	347,000	511,000
Property and equipment, net	410,000	407,000	388,000	294,000	334,000
Other noncurrent assets	36,000	58,000	22,000	22,000	22,000
Total assets	13	3	7	7	12
Accounts payable	183,000	215,000	150,000	540,000	333,000
Accrued expenses	383,000	278,000	368,000	560,000	578,000
Current portion of operating lease liability	139,000	0	217,000	180,000	164,000
Current portion of notes payable	61,000	56,000	33,000	0	—
Deferred revenue	32,000	12,000	18,000	44,000	0
Total current liabilities	798,000	561,000	786,000	1	1
Operating lease liability, less current portion	2	0	0	179,000	359,000
Notes payable, less current portion	145,000	206,000	156,000	0	—
Total liabilities	3	767,000	942,000	2	1
Commitments and contingencies (see notes)	—	—	—	—	—
Preferred stock, $0.001 par value, 10,000,000 shares authorized, none issued and outstanding as of December 31, 2025 and 2024	0	0	0	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 5,223,015 shares and 1,035,893 shares issued and outstanding as of December 31, 2025 and 2024, respectively	5,000	1,000	1,000	0	1,000
Additional paid-in capital	152	139	136	127	123
Accumulated deficit	−143	−136	−130	−122	−113
Total stockholders equity	10	3	6	5	10
Total liabilities and stockholders equity	13	3	7	7	12

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net loss	−6	−6	−8	−10	−8
Stock-based compensation	264,000	326,000	555,000	711,000	765,000
Depreciation and amortization	135,000	156,000	135,000	183,000	303,000
Operating lease liability	135,000	−8,000	—	—	—
Bad debt expense	14,000	2,000	−2,000	6,000	0
Accretion of interest on held-to-maturity investments	−30,000	0	—	—	—
Gain on sale of equipment	0	−28,000	0	28,000	0
Accounts receivable	121,000	−242,000	20,000	−42,000	−52,000
Prepaid expenses and other current assets	80,000	11,000	−10,000	−148,000	−52,000
Inventory	−200,000	1,000	58,000	148,000	−56,000
Other assets	22,000	−36,000	−4,000	0	12,000
Accounts payable	−32,000	65,000	−390,000	206,000	−71,000
Accrued expenses	105,000	−90,000	−192,000	−18,000	286,000
Deferred revenue	19,000	−6,000	−26,000	44,000	0
Net cash used in operating activities	−6	−6	−8	−9	−8
Purchase of held-to-maturity investments	−3	0	—	—	—
Maturity of held-to-maturity investments	2	0	—	—	—
Proceeds received on sale of property and equipment	0	28,000	0	4,000	1,000
Purchase of property and equipment	−138,000	−84,000	−149,000	−174,000	−100,000
Net cash used in investing activities	−1	−56,000	−149,000	−170,000	−99,000
Proceeds from the issuance of common stock, net	3	38,000	5	4	12
Proceeds from the exercise of warrants, net	10	2	3	0	1
Proceeds from the issuance of notes payable	0	25,000	114,000	0	—
Repayments of notes payable	−56,000	−42,000	−6,000	−5,000	−39,000
Net cash provided by financing activities	13	2	8	4	14
Increase (decrease) in cash and cash equivalents	6	−4	620,000	−5	6
Interest paid	22,000	22,000	4,000	1,000	11,000
Income taxes paid	0	0	0	0	0
Operating lease entered into for right-to-use asset	2	0	—	—	—
Notes payable incurred for the purchase of certain equipment	0	90,000	81,000	0	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is SenesTech, Inc.'s CIK number?

SenesTech, Inc.'s SEC CIK number is 0001680378 (1680378). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find SenesTech, Inc.'s SEC filings?

All of SenesTech, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did SenesTech, Inc. last report earnings?

SenesTech, Inc. (SNES) most recently filed an earnings 8-K with the SEC on May 12, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-034091). This is SenesTech, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is SenesTech, Inc.'s most recent earnings 8-K?

SenesTech, Inc.'s latest earnings 8-K (Item 2.02) was filed May 12, 2026 under accession 0001628280-26-034091. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View SenesTech, Inc.'s latest earnings 8-K →
Look up any company's CIK number →